A GPT-2 model fine-tuned with disease MeSH + protein sequence inputs and GRPO rewards produces more unique, valid, drug-like, high-PLAPT-affinity ligands than DrugGPT or DrugGen on five diabetic-nephropathy targets.
arXiv preprint arXiv:2502.02810 (2025)
2 Pith papers cite this work. Polarity classification is still indexing.
abstract
Recent advances in large language models (LLMs) have led to models that tackle diverse molecular tasks, such as chemical reaction prediction and molecular property prediction. Large-scale molecular instruction-tuning datasets have enabled sequence-only (e.g., SMILES or SELFIES) generalist molecular LLMs, and researchers are now exploring multimodal approaches that incorporate molecular structural information for further gains. However, a genuinely multimodal, generalist LLM that covers a broad spectrum of molecular tasks has yet to be fully investigated. We observe that naive next token prediction training ignores graph-structural information, limiting an LLM's ability to exploit molecular graphs. To address this, we propose (i) Molecular structure Preference Optimization (MolPO), which facilitates graph usage by optimizing preferences between pairs of correct and perturbed molecular structures, and (ii) an advanced graph encoder with a tailored pre-training strategy to improve the effect of graph utilization by MolPO. Building on these contributions, we introduce Mol-LLM, the first multimodal generalist model that (a) handles a broad spectrum of molecular tasks among molecular LLMs, (b) explicitly leverages molecular-structure information, and (c) takes advantage of extensive instruction tuning. Mol-LLM attains state-of-the-art or comparable results across the most comprehensive molecular-LLM benchmark-even on out-of-distribution datasets for reaction and property prediction, where it surpasses prior generalist molecular LLMs by a large margin.
years
2026 2representative citing papers
MolDA is a multimodal molecular model that uses a discrete large language diffusion backbone plus a hybrid graph encoder to achieve better global coherence and validity than autoregressive approaches.
citing papers explorer
-
DrugGen 2: A disease-aware language model for enhancing drug discovery
A GPT-2 model fine-tuned with disease MeSH + protein sequence inputs and GRPO rewards produces more unique, valid, drug-like, high-PLAPT-affinity ligands than DrugGPT or DrugGen on five diabetic-nephropathy targets.
-
MolDA: Molecular Understanding and Generation via Large Language Diffusion Model
MolDA is a multimodal molecular model that uses a discrete large language diffusion backbone plus a hybrid graph encoder to achieve better global coherence and validity than autoregressive approaches.